Maharashtra FDA chief flags 2,841% markup on IV infusion sets
The story in brief
Maharashtra FDA chief Tukaram Mundhe revealed an IV infusion set purchased at Rs 11.05 had an MRP of Rs 325, a 2,841% markup. He highlighted that patients lack pricing information, as medical devices are not subject to price controls under the Drugs (Prices Control) Order, 2013. Mundhe urged regulators to cap trade margins and monitor essential medical devices.